Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Intellia Therapeutics (NTLA) Q2 2026 Earnings
NTLA
11
May
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.28
-1.12
-0.97
-0.81
Details
Expected EPS
-0.910694
Actual EPS
-0.81
Surprise EPS
0.1
Surprise Percent
+11.06%
Description
Intellia Therapeutics (NTLA) has reported earnings of -0.81 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login